Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients-Reference-Cited by-同舟云学术

Fexofenadine, a Putative In Vivo P-glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients

Published:2017-05-27 Issue:6 Volume:102 Page:989-996
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Vanhove T¹,Bouillon T²,de Loor H¹,Annaert P²,Kuypers DRJ¹

Affiliation:

1. Department of Microbiology and Immunology, KU Leuven - University of Leuven, and Department of Nephrology and Renal Transplantation; University Hospitals Leuven; Leuven Belgium

2. Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences; KU Leuven - University of Leuven; Leuven Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.718/fullpdf

Reference50 articles.

1. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat.;Sattler;Drug Metab. Dispos.,1992

2. Human P-glycoprotein transports cyclosporin A and FK506.;Saeki;J. Biol. Chem.,1993

3. in vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.;Cummins;J. Pharmacol. Exp. Ther.,2003

4. Disposition of tacrolimus in isolated perfused rat liver: influence of troleandomycin, cyclosporine, and gg918.;Wu;Drug Metab. Dispos.,2003

5. Factors affecting cytochrome P-450 3A activity in cancer patients.;Baker;Clin. Cancer Res.,2004

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs;Biomedicine & Pharmacotherapy;2024-06

2. Intestinal P‐gp activity is reduced in postmenopausal women under breast cancer therapy;Clinical and Translational Science;2024-01

3. Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers;Clinical Pharmacology & Therapeutics;2022-06-29

4. ABCB1 in dermatology: roles in skin diseases and their treatment;Journal of Molecular Medicine;2021-08-09

5. Urinary Excretion of Nadolol as a Possible In Vivo Probe for Drug Interactions Involving P‐Glycoprotein;The Journal of Clinical Pharmacology;2021-01-29